MétaCan
Menu
Back to cohort
Record W4411238360 · doi:10.1016/j.ccell.2025.05.013

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma

2025· article· en· W4411238360 on OpenAlexaff
David Stahl, Philipp Gödel, Hyatt Balke‐Want, Rahil Gholamipoorfard, Paul Segbers, Luis Tetenborg, Mirjam Koker, Janina Dörr, Lisa Gregor, Daniel Bachurski, France Rose, Adrian Georg Simon, Zinaida Good, Josefine Jakob, Björn Häupl, Marieke Nill, Ruth Flümann, Tobias Riët, Dinah Lange, Stuart J. Blakemore, H. Baurmann, Conrad‐Amadeus Voltin, Nicole Potter, Lilli Schlözer, Max Freihammer, Svenja Wagener‐Ryczek, Andra-Iza Iuga, Jan‐Michel Heger, Hanna Ludwig, Julia Katharina Schleifenbaum, Jessica Propp, Paul J. Bröckelmann, Ron D. Jachimowicz, Gero Knittel, Sven Borchmann, Sabine Merkelbach‐Bruse, Christian P. Pallasch, Martin Peifer, Jan Rybniker, Alexander Quaas, Mark Nitz, Johannes Brägelmann, Thorsten Persigehl, Katarzyna Bożek, Sebastian J. Theobald, Reinhard Büttner, Thomas Oellerich, Michael Hallek, Sebastian Kobold, Markus Chmielewski, Hans Christian Reinhardt, Crystal L. Mackall, Nima Abedpour, Peter Borchmann, Roland T. Ullrich

Bibliographic record

VenueCancer Cell · 2025
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsUniversity of Toronto
FundersHorizon 2020European Research CouncilHector StiftungMinisterium für Kultur und Wissenschaft des Landes Nordrhein-WestfalenJosé Carreras Leukämie-StiftungBundesministerium für Bildung und ForschungHorizon 2020 Framework ProgrammeImhoff StiftungElse Kröner-Fresenius-StiftungBayerische ForschungsstiftungDeutsche ForschungsgemeinschaftFritz-Bender-StiftungDeutsche KrebshilfeWilhelm Sander-StiftungUniversität zu KölnEuropean CommissionDeutsches Zentrum für Infektionsforschung
KeywordsLymphomaMyeloidCancer researchMyeloid cellsCellBiologyImmunologyGenetics

Abstract

fetched live from OpenAlex

Despite the improvement, approximately 60% of patients with relapsed or refractory (r/r) aggressive B cell lymphoma (B-NHL) do not achieve durable benefit from CAR-T cell therapy. To elucidate factors associated with CAR-T therapy resistance, we conducted high-dimensional analyses of pre- and post-CAR-T cell specimens. In patients with non-durable response, we identified a prognostically relevant lymphoma-associated myeloid-monocytic (LAMM) gene signature. In-depth profiling revealed a distinct CSF1R + CD14 + CD68 + LAMM cell population in both human and murine B-NHL that inhibits CAR-T cell function and correlates with poor outcome. Cell-cell inference analysis uncovered that LAMM cells impair CAR-T cell function through a direct LAMM-T cell interaction via the PGE 2 -EP2/EP4 axis. In an autochthonous lymphoma mouse model, combined anti-CD19 CAR-T cell therapy with CSF1R blockade exhibited synergistic effects and improved survival. These findings provide strong rationale for combining anti-CD19 CAR-T cells with CSF1R inhibitors in treating r/r aggressive B-NHL patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.203
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.301
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCancer CellSame topicCAR-T cell therapy researchFrench-language works237,207